{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:03:59Z","timestamp":1778605439845,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Research","doi-asserted-by":"crossref","award":["Grant No. 21172043 and No.21441010"],"award-info":[{"award-number":["Grant No. 21172043 and No.21441010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13014-017-0785-0","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T12:35:34Z","timestamp":1488890134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma"],"prefix":"10.1186","volume":"12","author":[{"given":"Yi","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-ying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta-shan","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harun","family":"Badakhshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuai-le","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"785_CR1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400\u201312.","journal-title":"Lancet"},{"key":"785_CR2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson Jr JA, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281:1623\u20137.","journal-title":"JAMA"},{"key":"785_CR3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jnci\/86.14.1086","volume":"86","author":"JA Ajani","year":"1994","unstructured":"Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst. 1994;86:1086\u201391.","journal-title":"J Natl Cancer Inst"},{"key":"785_CR4","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/1097-0142(19930601)71:11<3774::AID-CNCR2820711147>3.0.CO;2-0","volume":"71","author":"H Choy","year":"1993","unstructured":"Choy H, Rodriguez FF, Koester S, Hilsenbeck S, Von Hoff DD. Investigation of taxol as a potential radiation sensitizer. Cancer. 1993;71:3774\u20138.","journal-title":"Cancer"},{"key":"785_CR5","first-page":"316","volume":"6","author":"DH Ilson","year":"2000","unstructured":"Ilson DH, Forastiere A, Arquette M, Costa F, Heelan R, Huang Y, et al. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J. 2000;6:316\u201323.","journal-title":"Cancer J"},{"key":"785_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/COC.0b013e3181131ca9","volume":"31","author":"X Zhang","year":"2008","unstructured":"Zhang X, Shen L, Li J, Li Y, Li J, Jin M. A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus. Am J Clin Oncol. 2008;31:29\u201333.","journal-title":"Am J Clin Oncol"},{"key":"785_CR7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/annonc\/mdg328","volume":"14","author":"MB Polee","year":"2003","unstructured":"Polee MB, Tilanus HW, Eskens FA, Hoekstra R, Van der Burg ME, Siersema PD, et al. Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus. Ann Oncol. 2003;14:1253\u20137.","journal-title":"Ann Oncol"},{"key":"785_CR8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1200\/JCO.1998.16.5.1826","volume":"16","author":"DH Ilson","year":"1998","unstructured":"Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, et al. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol. 1998;16:1826\u201334.","journal-title":"J Clin Oncol"},{"key":"785_CR9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/COC.0000000000000069","volume":"39","author":"H Tang","year":"2016","unstructured":"Tang H, Ma H, An S, Badakhshi H, Deng J, Zhang J, et al. A phase II study of concurrent chemoradiotherapy with paclitaxel and cisplatin for inoperable esophageal squamous cell carcinoma. Am J Clin Oncol. 2016;39:350\u20134.","journal-title":"Am J Clin Oncol"},{"key":"785_CR10","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1200\/JCO.2000.18.10.2032","volume":"18","author":"DJ Adelstein","year":"2000","unstructured":"Adelstein DJ, Rice TW, Rybicki LA, Larto MA, Ciezki J, Saxton J, et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol. 2000;18:2032\u20139.","journal-title":"J Clin Oncol"},{"key":"785_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00000421-200102000-00018","volume":"24","author":"II Schnirer","year":"2001","unstructured":"Schnirer II, Komaki R, Yao JC, Swisher S, Putnam J, Pisters PW, et al. Pilot study of concurrent 5-fluorouracil\/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction. Am J Clin Oncol. 2001;24:91\u20135.","journal-title":"Am J Clin Oncol"},{"key":"785_CR12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","volume":"20","author":"BD Minsky","year":"2002","unstructured":"Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167\u201374.","journal-title":"J Clin Oncol"},{"key":"785_CR13","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1200\/JCO.1999.17.9.2915","volume":"17","author":"A Ohtsu","year":"1999","unstructured":"Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and\/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915\u201321.","journal-title":"J Clin Oncol"},{"key":"785_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1748-717X-8-75","volume":"8","author":"L Tu","year":"2013","unstructured":"Tu L, Sun L, Xu Y, Wang Y, Zhou L, Liu Y, et al. Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma. Radiat Oncol. 2013;8:75.","journal-title":"Radiat Oncol"},{"key":"785_CR15","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1200\/JCO.2008.16.6918","volume":"26","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD, Liao Z, et al. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol. 2008;26:4551\u20136.","journal-title":"J Clin Oncol"},{"key":"785_CR16","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2013.53.6532","volume":"32","author":"C Mariette","year":"2014","unstructured":"Mariette C, Dahan L, Mornex F, Maillard E, Thomas PA, Meunier B, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014;32:2416\u201322.","journal-title":"J Clin Oncol"},{"key":"785_CR17","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","volume":"25","author":"L Bedenne","year":"2007","unstructured":"Bedenne L, Michel P, Bouch\u00e9 O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160\u20138.","journal-title":"J Clin Oncol"},{"key":"785_CR18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/annonc\/mdh230","volume":"15","author":"BF El-Rayes","year":"2004","unstructured":"El-Rayes BF, Shields A, Zalupski M, Heilbrun LK, Jain V, Terry D, et al. A phase II study of carboplatin and paclitaxel in esophageal cancer. Ann Oncol. 2004;15:960\u20135.","journal-title":"Ann Oncol"},{"key":"785_CR19","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.gassur.2005.05.005","volume":"9","author":"PW Chiu","year":"2005","unstructured":"Chiu PW, Chan AC, Leung SF, Leong HT, Kwong KH, Li MK, et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg. 2005;9:794\u2013802.","journal-title":"J Gastrointest Surg"},{"key":"785_CR20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1556-0864(15)31576-8","volume":"1","author":"S Wang","year":"2006","unstructured":"Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, et al. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol. 2006;1:252\u20139.","journal-title":"J Thorac Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-017-0785-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T12:05:02Z","timestamp":1498392302000},"score":1,"resource":{"primary":{"URL":"http:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-017-0785-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["785"],"URL":"https:\/\/doi.org\/10.1186\/s13014-017-0785-0","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]},"article-number":"47"}}